Indefinite Delivery Contract SPE2DB20D9214

The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to supply various pharmaceutical products and medical supplies in support of Department of Defense programs. Task orders issued against the contract procure medications, vaccines, and contraceptive implants for delivery to locations in Park Ridge, Illinois, with performance periods ranging from one day to several months. Notable orders include delivery of NUCALA auto-injectors valued at approximately $97K, Xolair syringes valued at $37K, Nexplanon implants valued at $16K, and Prolastin C vials valued at nearly $16K. No set-asides were specified in the awards provided. As the DOD's primary logistics combat support agency, the Defense Logistics Agency aims to ensure military readiness through efficient procurement and distribution of critical supplies to authorized customers worldwide. The contract and subsequent delivery orders facilitate this mission by replenishing pharmaceutical inventories relied upon by the military health system.

The indefinite-delivery/indefinite-quantity contract awarded to DMS Pharmaceutical Group Inc. by the Defense Logistics Agency established terms for the delivery of various medical supplies and pharmaceutical products on an as-needed basis to support Department of Defense operations. Task orders issued against the contract between 2020-2023 procured medications, vaccines, and contraceptive implants from DMS's facility in Park Ridge, Illinois, for distribution to military treatment facilities. Order values ranged from tens to hundreds of thousands of dollars, with performance periods spanning one day to multiple months. No set-aside provisions were applied to the awards. The contract and task orders allow the Defense Logistics Agency to fulfill its stockpile management responsibilities and maintain readiness of the military health system worldwide.